ENTRY       D01061                      Drug
NAME        Irinotecan hydrochloride (USP);
            Irinotecan hydrochloride hydrate (JP18);
            Irinotecan hydrochloride trihydrate;
            CPT 11;
            CPT-11;
            Campto (TN);
            Camptosar (TN);
            Onivyde (TN)
PRODUCT     CAMPTOSAR (Pharmacia & Upjohn Company LLC)
            ONIVYDE (Ipsen Biopharmaceuticals)
  GENERIC   IRINOTECAN HYDROCHLOIDE (BluePoint Laboratories)
            IRINOTECAN HYDROCHLOIDE (Gland Pharma Limited)
            IRINOTECAN HYDROCHLOIDE (Xiromed LLC)
            IRINOTECAN HYDROCHLORIDE (Actavis Pharma)
            IRINOTECAN HYDROCHLORIDE (Apotex Corp.)
            IRINOTECAN HYDROCHLORIDE (Apotex Corp.)
            IRINOTECAN HYDROCHLORIDE (Areva Pharmaceuticals)
            IRINOTECAN HYDROCHLORIDE (Areva Pharmaceuticals)
            IRINOTECAN HYDROCHLORIDE (Armas Pharmaceuticals)
            IRINOTECAN HYDROCHLORIDE (Armas Pharmaceuticals)
            IRINOTECAN HYDROCHLORIDE (Armas Pharmaceuticals)
            IRINOTECAN HYDROCHLORIDE (Eugia US LLC)
            IRINOTECAN HYDROCHLORIDE (Fresenius Kabi USA)
            IRINOTECAN HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            IRINOTECAN HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            IRINOTECAN HYDROCHLORIDE (Hospira)
            IRINOTECAN HYDROCHLORIDE (Ingenus Pharmaceuticals)
            IRINOTECAN HYDROCHLORIDE (Northstar Rx LLC)
            IRINOTECAN HYDROCHLORIDE (Qilu Pharmaceutical)
            IRINOTECAN HYDROCHLORIDE (Sagent Pharmaceuticals)
FORMULA     C33H38N4O6. 3H2O. HCl
EXACT_MASS  676.2875
MOL_WEIGHT  677.1848
CLASS       Antineoplastic
             DG01529  Topoisomerase inhibitor
              DG01526  Topoisomerase I inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02970  CES substrate
             DG02924  UGT substrate
              DG03183  UGT1A1 substrate
REMARK      Therapeutic category: 4240
            ATC code: L01CE02
            Chemical structure group: DG00726
            Product (DG00726): D01061<JP/US>
EFFICACY    Antineoplastic, Topoisomerase I inhibitor
  DISEASE   Adenocarcinoma of the pancreas [DS:H00019]
            Carcinoma of the colon or rectum [DS:H00020]
COMMENT     Camptothecin [CPD:C01897] derivative
            Irinotecan forms cleavable complex with DNA and inhibit DNA synthesis.
            Active form of prodrug: SN-38 [CPD:C11173]
TARGET      TOP1 [HSA:7150] [KO:K03163]
METABOLISM  Enzyme: CES [HSA:1066 221223 23491 8824]; CYP3A4 [HSA:1576], UGT1A1 [HSA:54658]
INTERACTION  
STR_MAP     map07042  Antineoplastics - agents from natural products
OTHER_MAP   map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
                L01CE Topoisomerase 1 (TOP1) inhibitors
                 L01CE02 Irinotecan
                  D01061  Irinotecan hydrochloride (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Irinotecan
                D01061  Irinotecan hydrochloride (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               424  Plant extract preparations
                4240  Plant extract preparations
                 D01061  Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01529  Topoisomerase inhibitor
               DG01526  Topoisomerase I inhibitor
                DG00726  Irinotecan
                 D01061  Irinotecan hydrochloride
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00726  Irinotecan
                 D01061  Irinotecan hydrochloride
              DG02970  CES substrate
               DG00726  Irinotecan
                D01061  Irinotecan hydrochloride
              DG02924  UGT substrate
               DG03183  UGT1A1 substrate
                DG00726  Irinotecan
                 D01061  Irinotecan hydrochloride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Isomerases (EC5)
               DNA topoisomerase
                TOP1
                 D01061  Irinotecan hydrochloride (USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01061  Irinotecan hydrochloride
              D01061  Irinotecan hydrochloride injection
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01061
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01061
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D01061
            Drug groups [BR:br08330]
             Antineoplastic
              DG01529  Topoisomerase inhibitor
               DG01526  Topoisomerase I inhibitor
                DG00726  Irinotecan
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00726  Irinotecan
              DG02970  CES substrate
               DG00726  Irinotecan
              DG02924  UGT substrate
               DG03183  UGT1A1 substrate
                DG00726  Irinotecan
            Prodrugs [br08324.html(DG00726)]
             DG00726
DBLINKS     CAS: 136572-09-3
            PubChem: 7848124
            ChEBI: 90881
            LigandBox: D01061
ATOM        47
            1   X   Cl    6.3178  -11.7757
            2   O0  O    10.5410  -11.7757
            3   C8y C    12.1100   -7.2100
            4   C8x C    12.1100   -8.6100
            5   C8x C    13.3224   -9.3100
            6   C8y C    14.5349   -8.6100
            7   C8y C    14.5349   -7.2100
            8   C8x C    13.3224   -6.5100
            9   N5x N    15.7473   -9.3100
            10  C8y C    16.9597   -8.6100
            11  C8y C    16.9597   -7.2100
            12  C8y C    15.7473   -6.5100
            13  O7a O    10.8976   -6.5100
            14  C7a C     9.6851   -7.2100
            15  O6a O     9.6851   -8.6100
            16  N1y N     8.4540   -6.4990
            17  C1x C     8.4543   -5.1101
            18  C1x C     7.2420   -4.4098
            19  C1y C     6.0294   -5.1095
            20  C1x C     6.0291   -6.4984
            21  C1x C     7.2414   -7.1987
            22  N1y N     4.8103   -4.4053
            23  C1x C     4.8107   -3.0101
            24  C1x C     3.5985   -2.3098
            25  C1x C     2.3859   -3.0094
            26  C1x C     2.3854   -4.4045
            27  C1x C     3.5977   -5.1049
            28  C8y C    18.2912   -9.0426
            29  N4y N    19.1141   -7.9100
            30  C1x C    18.2912   -6.7774
            31  C8y C    20.5100   -7.9100
            32  C8y C    21.2100   -9.1224
            33  C8y C    20.5196  -10.3179
            34  C8x C    19.1103  -10.3180
            35  C1z C    21.2195  -11.5304
            36  C7x C    22.6195  -11.5306
            37  O7x O    23.3099  -10.3351
            38  C1x C    22.6100   -9.1226
            39  O5x O    21.2100   -6.6976
            40  O6a O    23.3254  -12.7534
            41  C1b C    15.7473   -5.1100
            42  C1a C    14.5369   -4.4112
            43  C1b C    19.8195  -11.5304
            44  O1a O    21.2195  -12.9500
            45  C1a C    19.1121  -12.7636
            46  O0  O    10.5410  -11.7757
            47  O0  O    10.5410  -11.7757
BOND        49
            1     3   4 2
            2     4   5 1
            3     5   6 2
            4     6   7 1
            5     7   8 2
            6     3   8 1
            7     6   9 1
            8     9  10 2
            9    10  11 1
            10   11  12 2
            11    7  12 1
            12    3  13 1
            13   13  14 1
            14   14  15 2
            15   14  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
            19   19  20 1
            20   20  21 1
            21   16  21 1
            22   19  22 1
            23   22  23 1
            24   23  24 1
            25   24  25 1
            26   25  26 1
            27   26  27 1
            28   22  27 1
            29   10  28 1
            30   28  29 1
            31   29  30 1
            32   11  30 1
            33   29  31 1
            34   31  32 1
            35   32  33 2
            36   33  34 1
            37   33  35 1
            38   35  36 1
            39   36  37 1
            40   37  38 1
            41   32  38 1
            42   34  28 2
            43   31  39 2
            44   36  40 2
            45   12  41 1
            46   41  42 1
            47   35  43 1 #Down
            48   35  44 1 #Up
            49   43  45 1
BRACKET     1     8.6800  -12.7400    8.6800  -10.6400
            1    11.0600  -10.6400   11.0600  -12.7400
            1  3
  ORIGINAL  1    2
  REPEAT    1   46  47
///
